Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9619416 | 0.97 | TP53 (0.36) | TP53SIGMAR1PSIP1ESR1AOC3 | |
| Bromide SCHEMBL29193880 | 0.97 | TP53 (0.36) | TP53SIGMAR1PSIP1ESR1AOC3 | |
| SCHEMBL28095223 | 0.91 | TP53 (0.32) | TP53 | |
| SCHEMBL367263 | 0.85 | LTA4H (0.38) | TP53SIGMAR1ESR1CES2CES1 | |
| Bromide SCHEMBL25216737 | 0.83 | LTA4H (0.36) | TP53SIGMAR1ESR1CES2CES1 | |
| Hydrochloric Acid SCHEMBL11572419 | 0.83 | LTA4H (0.36) | TP53SIGMAR1ESR1CES2CES1 | |
| SCHEMBL3445934 | 0.83 | LTA4H (0.38) | TP53SIGMAR1CES2CES1PCSK9 | |
| SCHEMBL27678592 | 0.83 | LTA4H (0.36) | TP53SIGMAR1ESR1CES2CES1 | |
| Hydrochloric Acid SCHEMBL9619305 | 0.83 | LTA4H (0.36) | TP53SIGMAR1ESR1CES2CES1 | |
| Butane SCHEMBL27520586 | 0.83 | LTA4H (0.36) | TP53SIGMAR1ESR1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372209-B | Synthesis method of megastigmatrienone | 上海烟草集团有限责任公司 | 2022-09-13 | — | — | CN | claimed |
| CN-114573422-A | Treatment method of 3-methyl-3-butene-1-ol process waste liquid | 万华化学集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-113372209-A | Synthesis method of megastigmatrienone | 上海烟草集团有限责任公司 | 2021-09-10 | — | — | CN | claimed |
| CN-109651195-A | The method of 2- allyl acetonitrile isomerization reaction generation 3 pentene nitrile | 安徽省安庆市曙光化工股份有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-108849880-A | A kind of pesticidal preparations, preparation method and production equipment | 苏州富美实植物保护剂有限公司 | 2018-11-23 | — | — | CN | claimed |
| CN-106518805-A | New method for simple synthesis of 2, 4-disubstituted selenazole compound | 中国科学院生态环境研究中心 | 2017-03-22 | — | — | CN | claimed |
| CN-104011089-B | Process for producing alpha-olefin | 出光兴产株式会社 | 2016-08-24 | — | — | CN | claimed |
| CN-1269135-A | Pesticidal formulations for application on water | NIPPON BAYER FARM CHEMICALS CO (JP) | 2000-10-11 | — | — | CN | claimed |
| EP-0774514-B1 | A method for quantitatively determining creatine kinase and a reagent therefor | KYOWA MEDEX CO LTD (JP) | 2000-03-08 | — | — | EP | claimed |
| EP-0435073-A1 | Sulphonated propylphenyl phosphanes, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-03 | — | — | EP | claimed |
| EP-3848399-B1 | TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER | IDEMITSU KOSAN CO (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | IDEMITSU KOSAN CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230235202-A1 | PLASTICIZER FOR RESINS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20230234965-A1 | N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | JANSSEN PHARMACEUTICA NV (BE) | 2023-07-27 | — | — | US | disclosed |
| CN-115996701-A | Method for treating keratin fibres using a high concentration of a specific amino acid | 莱雅公司 | 2023-04-21 | — | — | CN | disclosed |
| US-4265827-A | METHYLCYCOHEXYL-O-ANISYLARSINE OPTICALLY ACTIVE CATALYST | MONSANTO COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4261919-A | OF BETA-SUBSTITUTED-ALPHA-ACYLAMIDO-ACRYLIC ACIDS TO YIELD OPTICALLY ACTIVE MIXTURE | MONSANTO COMPANY (US) | 1981-04-14 | — | — | US | disclosed |
| US-4124533-A | HYDROGENATION CATALYSTS | MONSANTO COMPANY (US) | 1978-11-07 | — | — | US | disclosed |
| US-4119652-A | HYDROGENATION CATALYSTS; COORDINATION COMPOUNDS OF IRIDIUM, RHODIUM OR RUTHENIUM WITH PHOSPHINE OR ARSINE LIGANDS; OPTICALLY ACTIVE | MONSANTO COMPANY (US) | 1978-10-10 | — | — | US | disclosed |
| US-3968147-A | COORDINATION CATALYST | MONSANTO COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234965-A1 | N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | MCL1, BCL2L1, BAK1 | TP53 36/4885SIGMAR1 3818/4885PSIP1 1874/4885 |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | H1-0, C9, C5 | TP53 4304/4885SIGMAR1 796/4885PSIP1 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.